This menu provides the list of EV miRNAs identified by high-throughput analyses.
Refresh all contents
Search:
Dataset accession
miRBase accession
Mature name
Orthologous group
Superdomain:
All
Prokaryote
Eukaryote
Filter datasets:
- "Sample type" indicates the source from which EVs originated (e.g. B cell, serum).
- "Sample status" indicates the condition of the source from which EVs originated (e.g. Normal, miR-146a-treated, Patients of hernia).
By species
Homo sapiens
Mus musculus
In vitro/In vivo
In vitro
In vivo
By sample type
B cell (Raji)
Breast cancer cells (MCF7)
Breast cancer cells (MDA-MB-231)
Drug-resistant acute lymphoblastic leukemia cell (CCRF-CEM MDR variant VLB100)
Fetal human colon epithelial cell (FHC)
Gastric cancer cells (SGC-7901)
Liver cancer cells (CSQT-2)
Liver cancer cells (HCC-LM3)
Liver cancer cells (HepG2)
Liver cancer cells (MHCC-97L)
Lung cancer cells (A549)
Mammary gland cells (MCF10A)
Mammary gland cells (NMuMG)
Plasma
Serum
T cell (Jurkat)
By sample status
24 hr culture
72 hr culture
Cisplatin-resistant
Normal
Normal_Agilent
Omeprazole-treated
Transplant islets into mouse xenotransplantation-rejected
Maximum false positive rate (FPR):
Maximum true positive rate (TPR):
- FPR is the probability that an absent miRNA accidently have higher intensity than that miRNA.
- TPR is the percentile of miRNA among the present miRNAs.
Please see user manual in the contact us/help menu for detail.
Number of molecules in one page:
100
200
All
The downloaded CSV file is not exactly the same as the displayed table. Opening CSV file with Excel can impair its content.
Since there are multiple primers in the microarray, the same miRNA can have several FPR and TPR values.
Mature name
miRBase accession
FPR
TPR
Publication
Orthologous group
Identification count
All / Prokaryote / Eukaryote
(FPR<0.05,TPR<0.5)
hsa-miR-1226-5p
MIMAT0005576
1.2e-3
4.3e-1
Unidirectional transfer of microRNA-loaded exosomes from T cells to antigen-presenting cells.
Nat Commun. 2011;2:282. doi: 10.1038/ncomms1285.
MIPF0000444_1
18
/
0
/
18
hsa-miR-1226-5p
MIMAT0005576
2.7e-3
4.1e-1
Unidirectional transfer of microRNA-loaded exosomes from T cells to antigen-presenting cells.
Nat Commun. 2011;2:282. doi: 10.1038/ncomms1285.
MIPF0000444_1
18
/
0
/
18
ptr-miR-1226
MIMAT0005578
8.5e-6
5.0e-1
Microparticle conferred microRNA profiles--implications in the transfer and dominance of cancer traits.
Mol Cancer. 2012 Jun 8;11:37. doi: 10.1186/1476-4598-11-37.
MIPF0000444_1
18
/
0
/
18
hsa-miR-1226-5p
MIMAT0005576
0.0e+0
4.6e-2
Circulating exosomal microRNAs as biomarkers of colon cancer.
PLoS One. 2014 Apr 4;9(4):e92921. doi: 10.1371/journal.pone.0092921. eCollection 2014.
MIPF0000444_1
18
/
0
/
18
hsa-miR-1226-5p
MIMAT0005576
0.0e+0
3.9e-1
Combined Evaluation of a Panel of Protein and miRNA Serum Exosome Biomarkers for Pancreatic Cancer Diagnosis Increases Sensitivity and Specificity.
Int J Cancer. 2014 Nov 12. doi: 10.1002/ijc.29324.
MIPF0000444_1
18
/
0
/
18
hsa-miR-1226-5p
MIMAT0005576
0.0e+0
4.6e-1
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000444_1
18
/
0
/
18
hsa-miR-1226-5p
MIMAT0005576
0.0e+0
2.3e-2
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000444_1
18
/
0
/
18
hsa-miR-1226-5p
MIMAT0005576
0.0e+0
1.9e-1
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000444_1
18
/
0
/
18
hsa-miR-1226-5p
MIMAT0005576
0.0e+0
4.0e-2
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000444_1
18
/
0
/
18
mml-miR-1226
MIMAT0005579
1.0e-3
1.0e-3
Tissue-specific exosome biomarkers for noninvasively monitoring immunologic rejection of transplanted tissue.
J Clin Invest. 2017 Apr 3;127(4):1375-1391. doi: 10.1172/JCI87993. Epub 2017 Mar 20.
MIPF0000444_1
18
/
0
/
18
ptr-miR-1226
MIMAT0005578
1.0e-3
1.0e-3
Tissue-specific exosome biomarkers for noninvasively monitoring immunologic rejection of transplanted tissue.
J Clin Invest. 2017 Apr 3;127(4):1375-1391. doi: 10.1172/JCI87993. Epub 2017 Mar 20.
MIPF0000444_1
18
/
0
/
18
hsa-miR-1226-5p
MIMAT0005576
0.0e+0
4.8e-1
Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.
MIPF0000444_1
18
/
0
/
18
hsa-miR-1226-5p
MIMAT0005576
0.0e+0
3.9e-1
Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.
MIPF0000444_1
18
/
0
/
18
hsa-miR-1226-5p
MIMAT0005576
0.0e+0
4.2e-1
Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.
MIPF0000444_1
18
/
0
/
18
hsa-miR-1226-5p
MIMAT0005576
0.0e+0
1.8e-1
Tumor microenvironment interruption: a novel anti-cancer mechanism of Proton-pump inhibitor in gastric cancer by suppressing the release of microRNA-carrying exosomes.
Am J Cancer Res. 2017 Sep 1;7(9):1913-1925. eCollection 2017.
MIPF0000444_1
18
/
0
/
18
hsa-miR-1226-5p
MIMAT0005576
0.0e+0
2.0e-1
Tumor microenvironment interruption: a novel anti-cancer mechanism of Proton-pump inhibitor in gastric cancer by suppressing the release of microRNA-carrying exosomes.
Am J Cancer Res. 2017 Sep 1;7(9):1913-1925. eCollection 2017.
MIPF0000444_1
18
/
0
/
18
hsa-miR-1226-5p
MIMAT0005576
0.0e+0
2.3e-1
Tumor microenvironment interruption: a novel anti-cancer mechanism of Proton-pump inhibitor in gastric cancer by suppressing the release of microRNA-carrying exosomes.
Am J Cancer Res. 2017 Sep 1;7(9):1913-1925. eCollection 2017.
MIPF0000444_1
18
/
0
/
18
hsa-miR-1226-5p
MIMAT0005576
0.0e+0
2.6e-1
Tumor microenvironment interruption: a novel anti-cancer mechanism of Proton-pump inhibitor in gastric cancer by suppressing the release of microRNA-carrying exosomes.
Am J Cancer Res. 2017 Sep 1;7(9):1913-1925. eCollection 2017.
MIPF0000444_1
18
/
0
/
18
hsa-miR-1226-5p
MIMAT0005576
0.0e+0
5.8e-2
Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer.
Nat Commun. 2018 Jan 15;9(1):191. doi: 10.1038/s41467-017-02583-0.
MIPF0000444_1
18
/
0
/
18
hsa-miR-1226-5p
MIMAT0005576
0.0e+0
2.7e-1
Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer.
Nat Commun. 2018 Jan 15;9(1):191. doi: 10.1038/s41467-017-02583-0.
MIPF0000444_1
18
/
0
/
18
hsa-miR-1226-5p
MIMAT0005576
3.3e-2
3.3e-2
Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer.
Nat Commun. 2018 Jan 15;9(1):191. doi: 10.1038/s41467-017-02583-0.
MIPF0000444_1
18
/
0
/
18
hsa-miR-1226-5p
MIMAT0005576
3.0e-2
3.0e-2
Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer.
Nat Commun. 2018 Jan 15;9(1):191. doi: 10.1038/s41467-017-02583-0.
MIPF0000444_1
18
/
0
/
18
[1]